5results about How to "Fast preparation method" patented technology

This invention discloses a method for preparing and applying a sodium borohydride-modified self-supporting anode for AEM water electrolyzers. Firstly, an amorphous ternary metal hydroxyl oxide precursor is grown in situ on a nickel substrate via room temperature liquid phase deposition. The process involves the presence of Co in solution. 2+ Fe 3+ Ni ions are introduced through slight corrosion of the nickel foam matrix. 2+ The ions, the three, and the OH- produced by hydrolysis ⁻ Co-deposition occurs under the influence of dissolved oxygen, leading to the self-assembly of amorphous nanosheet structures on the substrate surface. Subsequently, a mild chemical reduction treatment with sodium borohydride solution is used to obtain a structurally stable and high-performance self-supporting electrode. The method described in this embodiment is mild, simple, low-cost, and has good versatility.

The application discloses a vanadium pentoxide-based magnesium battery positive electrode material and a preparation method thereof. The application obtains flower-spherical vanadium pentoxide through a hydrothermal reaction of an ammonium metavanadate and a mixed solution of reactants and subsequent calcination; the method has high production efficiency, is convenient to produce, has short preparation time, is low in cost and has good repeatability. The flower-spherical vanadium pentoxide nanomaterial is used as a magnesium battery positive electrode material, more surface active sites can be exposed, ion transmission channels are increased, the problem of stacking and agglomeration of vanadium pentoxide nanosheets in a cycle process is solved, the exposed (001) crystal face reduces the interface side reaction of an electrode and an electrolyte surface, the storage capacity of vanadium pentoxide is greatly improved, the vanadium pentoxide has good cycle stability and is an excellent magnesium battery positive electrode material.

The application relates to the field of biotechnology, in particular to a nanobody targeting annexin A1 and a preparation method and application thereof, discloses a nanobody targeting annexin A1, the nanobody comprises a nanobody Nb6, wherein the amino acid sequence of the nanobody Nb6 is shown in Seq.ID NO.1, the nanobody Nb4 provided has higher affinity with annexin A1, the nanobody can be used for targeted action on annexin A1, has high-strength combination capacity with annexin A1, is favorable for development of a nanobody related medicine of annexin A1, realizes targeted treatment and imaging of tumors, and has very great clinical application value. Meanwhile, a molecular probe can be prepared based on the nanobody, the molecular probe is specifically combined with a tumor blood vessel surface annexin antigen, is applied to specific imaging and diagnosis of tumors, and is used for delivery of related medicines, and is widely applied.

This invention discloses a method for rapidly preparing high-performance GeTe thermoelectric materials, wherein the thermoelectric material has the general chemical formula Ge. x M 1‑ x Te y N 1‑y Where M is one or more of the elements Cd, Mn, Cr, Fe, Cu, Sb, Ag, In, Pb, and Zn, and N is one or more of the elements Se, I, S, Si, Br, and C, where x and y are the molar numbers, 0.6 <x≤1,0.5<y≤1。Ge x M 1‑x Te y N 1‑y The preparation methods mainly include low-energy ball milling mixing, cold pressing, high-energy ball milling, and spark plasma sintering. The Ge described in this invention... x M 1‑x Te y N 1‑y Thermoelectric materials have the advantages of simple, rapid, and safe preparation methods, and can effectively reduce thermal conductivity, improve power factor, and enhance compressive strength, thus expanding the application fields of thermoelectric materials.

The invention discloses an aurone-lignan glycoside compound separated from Tibetan monascus and application of the aurone-lignan glycoside compound in resisting non-alcoholic fatty liver. The structure of the aurone-lignan glycoside compound is shown as a formula I or pharmaceutically acceptable salt of the aurone-lignan glycoside compound. The compound can significantly reduce the levels of ALP, AST, ALT, TG, TC and LDL-C in serum of a non-alcoholic fatty liver model golden hamster, can significantly increase the levels of APN and HDL-C, and has significant anti-non-alcoholic fatty liver activity. The invention discloses an application of the neoaurone and lignan glycoside compound in preparation of a medicine for reducing blood fat. The invention discloses an application of the neoaurone-lignan glycoside compound in preparation of a medicine for resisting the non-alcoholic fatty liver disease, and further discloses an application of the neoaurone-lignan glycoside compound in preparation of a medicine for resisting the non-alcoholic fatty liver disease.